Viral hepatitis.
The prevalence of hepatitis A antibody, which is indicative of immunity to hepatitis A virus, increased among U.S. born persons aged 6-19, but decreased among persons aged 40 years and over. Hepatitis B virus (HBV) infection among persons aged 6-19 has decreased in recent years. By 2003-2006, over 90% of children had received at least one dose of the recommended three-dose series of hepatitis B vaccine. Prevalence of infection with hepatitis C virus (HCV) decreased among those at highest risk of infection including males and Mexican- American and non-Hispanic black populations. Despite this decrease, the prevalence of infection remains higher in the non-Hispanic black population. The peak prevalence of HCV infection has shifted over time from persons aged 30-39 years (3.9%) to those aged 40-49 years (4.3%).
McQuillian
Geraldine M
GM
Centers for Disease Control and Prevention National Center for Health Statistics 3311 Toledo Road, Hyattsville, Maryland 20782, USA.
Kruszon-Moran
Deanna
D
Denniston
Maxine M
MM
Hirsch
Rosemarie
R
D000293:Adolescent; D000328:Adult; D017677:Age Distribution; D002648:Child; D005260:Female; D006506:Hepatitis A / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D035922:Hepatitis A Antibodies / Q000097:blood; D006509:Hepatitis B / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D006526:Hepatitis C / Q000453:epidemiology* / Q000276:immunology / Q000517:prevention & control* / Q000821:virology; D006801:Humans; D008297:Male; D009749:Nutrition Surveys; D011159:Population Surveillance; D015995:Prevalence; D011634:Public Health; D012111:Residence Characteristics; D012307:Risk Factors; D016036:Seroepidemiologic Studies; D017678:Sex Distribution; D014195:Travel; D014481:United States / Q000453:epidemiology; D014611:Vaccination
D035922:Hepatitis A Antibodies